Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicaid AWP Reform Planned By House Energy & Commerce Panel

This article was originally published in The Pink Sheet Daily

Executive Summary

“We are going to attempt to legislate in this area in the next Congress,” Committee Chairman Barton (R-Texas) says at a hearing on Medicaid reimbursement. Barton cites Medicare’s average sales price system and the methods employed by Texas as potential models for reform.

You may also be interested in...



"Best Price" Rebate Would Be Eliminated In Bush Administration Budget

The President's fiscal year 2006 budget request proposes adopting a budget-neutral flat rebate, "allowing private purchasers to negotiate lower prices." CMS Administrator McClellan says further details will be put forth as the agency works with lawmakers.

"Best Price" Rebate Would Be Eliminated In Bush Administration Budget

The President's fiscal year 2006 budget request proposes adopting a budget-neutral flat rebate, "allowing private purchasers to negotiate lower prices." CMS Administrator McClellan says further details will be put forth as the agency works with lawmakers.

Medicaid Reform Must Decrease Drug Prices For States – HHS Secretary

States should pay "the same low rate" for drugs as pharmacies and Medicare, Secretary Leavitt says. Reforms could save the federal government $15 bil. and the states $11 bil. over the next 10 years; details will be outlined in the President's forthcoming fiscal year 2006 budget request.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel